Pacira BioSciences (PCRX) Change in Acquisitions & Divestments (2011 - 2026)

Pacira BioSciences' Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at $22.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 67.51% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $227.1 million (up 10.51% YoY), while the FY2025 annual figure was $273.8 million, up 52.48% from the prior year.
• Change in Acquisitions & Divestments was $22.5 million for Q1 2026 at Pacira BioSciences, down from $47.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $126.2 million in Q1 2023 to a low of $22.5 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $59.4 million across 5 years, with a median of $50.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments plunged 85.8% in 2022, then soared 97.13% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $84.9 million in 2022, then tumbled by 57.5% to $36.1 million in 2023, then jumped by 30.05% to $46.9 million in 2024, then gained by 0.42% to $47.1 million in 2025, then slumped by 52.27% to $22.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $22.5 million (Q1 2026), $47.1 million (Q4 2025), and $86.2 million (Q3 2025), per Business Quant data.